3/26
07:00 am
blrx
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
Low
Report
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
3/25
09:02 pm
blrx
BioLine Rx Ltd (BLRX) Full Year 2025 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
Medium
Report
BioLine Rx Ltd (BLRX) Full Year 2025 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
3/23
10:47 am
blrx
BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/23
07:15 am
blrx
BioLineRx GAAP EPS of $0.00 beats by $0.68, revenue of $1.18M misses by $0.3M [Seeking Alpha]
High
Report
BioLineRx GAAP EPS of $0.00 beats by $0.68, revenue of $1.18M misses by $0.3M [Seeking Alpha]
3/23
07:09 am
blrx
BioLineRx Reports 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
BioLineRx Reports 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/23
07:00 am
blrx
BioLineRx Reports 2025 Financial Results and Provides Corporate Update
Medium
Report
BioLineRx Reports 2025 Financial Results and Provides Corporate Update
3/16
07:08 am
blrx
BioLineRx to Report 2025 Annual Results on March 23, 2026 [Yahoo! Finance]
Low
Report
BioLineRx to Report 2025 Annual Results on March 23, 2026 [Yahoo! Finance]
3/16
07:00 am
blrx
BioLineRx to Report 2025 Annual Results on March 23, 2026
Low
Report
BioLineRx to Report 2025 Annual Results on March 23, 2026